Pao Chung Lee

Innovation, efficacy, and safety are the key factors in developing outstanding medicines. For Golden Biotech, these principles have guided the development of our lead compound, Antroquinonol. For more than a decade, Golden Biotech has been dedicated to advancing Antroquinonol, focusing on conducting critical preclinical and clinical studies targeting diseases with high unmet medical needs. Antroquinonol has completed multiple Phase 2 clinical trials in oncology and infectious diseases. Our ultimate goal is to actively treat patients and improve their quality of life. To achieve this mission, we are seeking strategic partners to join us in advancing this journey. Golden Biotech plans to initiate Phase 3 clinical trials in selected key indications to reach the next major clinical milestones. The ultimate objective is to submit a New Drug Application (NDA) and obtain regulatory approvals from the U.S. FDA and other regulatory authorities worldwide.

​Utilize a strong background in biomedicine and pharmaceuticals combined with extensive client communication experience to translate our company's core technological value into tangible market opportunities. ​Key responsibilities include: ​Proactively identifying and developing strategic partnerships with potential clients and collaborators both domestically and internationally. ​Conducting in-depth market analysis and competitive intelligence to guide business strategy. ​Successfully negotiating and executing partnership agreements to ensure the achievement of sales and business expansion goals.

At Spirit, I am mainly responsible for product business development and marketing. I am responsible for the Greater Taipei area, leading a team of four people, focusing on expanding the customer base of clinics and related medical institutions, increasing the market share of the company's products, and leading the team to achieve the company's performance target of 110%. Actively establish and maintain good relationships with medical professionals, provide product information, conduct technical exchanges, and ensure that products meet market demand.

Achievement: • Leading the team achieved a 100% performance rate in vaccine sales for the year 2020, with approximately 35 million Sales. R & R • The communication bridge between the company and front-line business operations and assisting in resolving market issues. • Exceeded sales targets with well-developed sales strategy and empowering team coaching. Reason for Leaving: Laid off

Philippines Business Development & Market Expansion Spearheaded the company’s market entry and long-term business development in the Philippines, building the local operation from the ground up and establishing a sustainable commercial presence over 11 years. Established and led a local business team, developed sales channels, built strategic partnerships, and expanded the company’s market reach across key local customer segments. Navigated local regulatory requirements, business practices, and market dynamics, enabling successful market penetration and sustainable commercial operations. Built strong credibility and trust with physicians, healthcare professionals, and local partners, supporting the company’s reputation and long-term business growth. Strengthened the company’s local brand positioning as a provider of high-quality, clinically credible, and reasonably priced products. Key Responsibilities Designed and executed market development and sales strategies to drive business growth, enhance market penetration, and improve commercial performance. Assessed market conditions, competitive activities, customer feedback, and regulatory trends to refine business direction and optimize sales strategies. Led and coached local team members on sales execution, customer engagement, product positioning, and cross-selling strategies. Developed and maintained relationships with key opinion leaders, physicians, distributors, and local business partners to support product adoption and market expansion. Drove revenue growth by improving channel effectiveness, strengthening customer relationships, and identifying new business opportunities.

Achievement: • 2008 Sales performance achieve rate at 105%, total around 190,000,000 THB • Conducting a Phase III clinical trials for the product Sulfin in Thailand, responsible for coordinating with local Principal Investigators and Taiwan teams. R & R: • Sharing Taiwan's product sales experience and integrating it with local medical system practices. • Coached employees in successful selling methods and encouraged cross-selling to drive revenue. Reason to leaving: Transferred to the Philippines.